Gil M Labrucherie - Net Worth and Insider Trading
Gil M Labrucherie Net Worth
The estimated net worth of Gil M Labrucherie is at least $861,298 dollars as of 2024-10-10. Gil M Labrucherie is the Director of Rezolute Inc and owns about 99,673 shares of Rezolute Inc (RZLT) stock worth over $465,473. Gil M Labrucherie is also the SVP, COO & CFO of Nektar Therapeutics and owns about 312,905 shares of Nektar Therapeutics (NKTR) stock worth over $395,825. Details can be seen in Gil M Labrucherie's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gil M Labrucherie has not made any transactions after 2022-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gil M Labrucherie
Gil M Labrucherie Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gil M Labrucherie owns 3 companies in total, including Nektar Therapeutics (NKTR) , Rezolute Inc (RZLT) , and Acelyrin Inc (SLRN) .
Click here to see the complete history of Gil M Labrucherie’s form 4 insider trades.
Insider Ownership Summary of Gil M Labrucherie
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NKTR | Nektar Therapeutics | 2022-05-16 | SVP & COO & CFO |
RZLT | Rezolute Inc | 2022-05-04 | director |
SLRN | Acelyrin Inc | 2023-08-02 | Interim CFO |
Gil M Labrucherie Latest Holdings Summary
Gil M Labrucherie currently owns a total of 2 stocks. Among these stocks, Gil M Labrucherie owns 99,673 shares of Rezolute Inc (RZLT) as of May 4, 2022, with a value of $465,473 and a weighting of 54.04%. Gil M Labrucherie also owns 312,905 shares of Nektar Therapeutics (NKTR) as of May 16, 2022, with a value of $395,825 and a weighting of 45.96%.
Latest Holdings of Gil M Labrucherie
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RZLT | Rezolute Inc | 2022-05-04 | 99,673 | 4.67 | 465,473 |
NKTR | Nektar Therapeutics | 2022-05-16 | 312,905 | 1.27 | 395,825 |
Holding Weightings of Gil M Labrucherie
Gil M Labrucherie Form 4 Trading Tracker
According to the SEC Form 4 filings, Gil M Labrucherie has made a total of 2 transactions in Rezolute Inc (RZLT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Rezolute Inc is the acquisition of 52,631 shares on May 4, 2022, which cost Gil M Labrucherie around $199,998.
According to the SEC Form 4 filings, Gil M Labrucherie has made a total of 15 transactions in Nektar Therapeutics (NKTR) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Nektar Therapeutics is the sale of 17,448 shares on May 16, 2022, which brought Gil M Labrucherie around $68,920.
Insider Trading History of Gil M Labrucherie
- 1
Gil M Labrucherie Trading Performance
GuruFocus tracks the stock performance after each of Gil M Labrucherie's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gil M Labrucherie is -15.12%. GuruFocus also compares Gil M Labrucherie's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gil M Labrucherie within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gil M Labrucherie's insider trading performs compared to the benchmark.
Performance of Gil M Labrucherie
Gil M Labrucherie Ownership Network
Gil M Labrucherie Owned Company Details
What does Nektar Therapeutics do?
Who are the key executives at Nektar Therapeutics?
Gil M Labrucherie is the SVP & COO & CFO of Nektar Therapeutics. Other key executives at Nektar Therapeutics include SVP & General Counsel Mark Andrew Wilson , Chief R&D Officer Jonathan Zalevsky , and director & President & CEO Howard W Robin .
Nektar Therapeutics (NKTR) Insider Trades Summary
Over the past 18 months, Gil M Labrucherie made no insider transaction in Nektar Therapeutics (NKTR). Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 111,800 shares made by Howard W Robin , a net sale of 52,375 shares made by Jonathan Zalevsky , and a net sale of 41,460 shares made by Mark Andrew Wilson .
In summary, during the past 3 months, insiders sold 27,398 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 27,398 shares. During the past 18 months, 289,853 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 289,853 shares.
Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nektar Therapeutics Insider Transactions
Gil M Labrucherie Mailing Address
Above is the net worth, insider trading, and ownership report for Gil M Labrucherie. You might contact Gil M Labrucherie via mailing address: 150 Industrial Road, San Carlos Ca 94070.